ASPPH logo


School & Program Updates

School & Program Updates

UNC Lineberger Grant Application Earns NCI’s Highest Recognition

The UNC Lineberger Comprehensive Cancer Center has earned an “exceptional” rating from the National Cancer Institute (NCI) for a major grant application associated with the center’s multidisciplinary research.

[Photo: Dr. Kurt Ribisl (left) and Dr. Andrew Olshan are leaders, respectively, of UNC Lineberger Comprehensive Cancer Center’s Cancer Prevention and Control and Cancer Epidemiology programs.]

The rating was given to UNC Lineberger’s application to the NCI for renewal of a five-year grant that supports multidisciplinary research and shared scientific core resources for hundreds of scientists and clinicians in addition to other key center functions. The rating is the highest that a cancer center can earn for the application.

“This recognition speaks to the excellence of our researchers’ work in a wide range of disciplines, from clinical research to cancer genetics to breast cancer and molecular therapeutics,” said Dr. Norman E. Sharpless, director of UNC Lineberger and  Wellcome Distinguished Professor in Cancer Research. “We are striving to leverage this high-impact research to ultimately reduce cancer incidence and mortality across North Carolina.”

The rating followed a rigorous institutional review with a site visit by a panel of 22 peer reviewers. UNC Lineberger researchers made presentations to demonstrate the depth and breadth of their work spanning the basic sciences, population sciences, clinical sciences and translational research.

Researchers presented in each of nine program areas — cancer cell biology, immunology research, molecular therapeutics, virology, cancer genetics, clinical and translational research, breast cancer, cancer prevention and control, and cancer epidemiology.

They highlighted initiatives such as the planned launch of a new immunotherapy program, in which researchers plan to fight cancer using immune system T-cells engineered to recognize and directly target a patient’s own cancer. In cancer genetics, they highlighted work on an ongoing clinical trial to analyze the genetic profiles of patients’ tumors in order to find clinically actionable genetic alterations.

A number of faculty members from the UNC Gillings School of Global Public Health — including biostatisticians, epidemiologists, health behaviorists and others — are members and leaders at the cancer center. UNC Lineberger’s population sciences programs – Cancer Prevention and Control and Cancer Epidemiology – made a good showing in NCI’s review. They were rated “exceptional” and “outstanding,” respectively.

Dr. Kurt Ribisl, professor of health behavior in the Gillings School, and Dr. Ethan Basch, associate professor of health policy and management in the Gillings School and of hematology and oncology in the UNC School of Medicine, lead the Cancer Prevention and Control program. Dr. Andrew Olshan, professor and chair, and Dr. Melissa Troester, associate professor, both in the Gillings School’s department of epidemiology, lead the Cancer Epidemiology program.


Read more: